Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Twist Bioscience Corporation (TWST : NSDQ)

• Company Description    Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California. Number of Employees: 923

• Price / Volume Information    Yesterday's Closing Price: $36.98 Daily Weekly Monthly 20 Day Moving Average: 890,452 shares Shares Outstanding: 59.92 (millions) Market Capitalization: $2,215.70 (millions) Beta: 2.41 52 Week High: $60.90 52 Week Low: $27.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.34% 4.12% 12 Week -6.38% -18.84% Year To Date -20.42% -24.82%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 681 GATEWAY BLVD. - SOUTH SAN FRANCISCO,CA 94080 USA ph: 800-719-0671 fax: - abitting@twistbioscience.com http://www.twistbioscience.com

• General Corporate Information    Officers Emily M. Leproust - Chief Executive Officer and Chair of the Board of Adam Laponis - Chief Financial Officer Robert F. Werner - Chief Accounting Officer Nelson C. Chan - Director Robert Chess - Director Peer Information Twist Bioscience Corporation (CORR.) Twist Bioscience Corporation (RSPI) Twist Bioscience Corporation (CGXP) Twist Bioscience Corporation (BGEN) Twist Bioscience Corporation (GTBP) Twist Bioscience Corporation (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 90184D100 SIC: 2836 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/01/25 Share - Related Items Shares Outstanding: 59.92 Most Recent Split Date: (:1) Beta: 2.41 Market Capitalization: $2,215.70 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.45 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.17 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/01/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.01 Price/Cash Flow: - Price / Sales: 6.37 EPS Growth vs. Year Ago Period: 16.46% vs. Previous Quarter: -24.53% Sales Growth vs. Year Ago Period: 23.23% vs. Previous Quarter: 4.60% ROE 06/30/25 - - 03/31/25 - -33.48 12/31/24 - -32.69 ROA 06/30/25 - - 03/31/25 - -25.34 12/31/24 - -25.25 Current Ratio 06/30/25 - - 03/31/25 - 4.51 12/31/24 - 4.96 Quick Ratio 06/30/25 - - 03/31/25 - 4.24 12/31/24 - 4.62 Operating Margin 06/30/25 - - 03/31/25 - -44.77 12/31/24 - -49.01 Net Margin 06/30/25 - - 03/31/25 - -54.98 12/31/24 - -59.76 Pre-Tax Margin 06/30/25 - - 03/31/25 - -54.87 12/31/24 - -59.60 Book Value 06/30/25 - - 03/31/25 - 7.38 12/31/24 - 7.64 Inventory Turnover 06/30/25 - - 03/31/25 - 7.65 12/31/24 - 6.87 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.03 12/31/24 - 0.03 Debt-to-Capital 06/30/25 - - 03/31/25 - 3.30 12/31/24 - 3.19

Powered by Zacks Investment Research ©